Physician profile
Shannon Lambert
NPI 1598113243
$1,258.31
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $568 · 2023: $471 · 2024: $15.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.74 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $332.19 | 2021-2023 | Entyvio |
| Janssen Biotech, INC. | $242.83 | 2022-2023 | Stelara, Simponi, Simponi Aria |
| Abbvie INC. | $180.67 | 2021-2023 | |
| Genzyme Corporation | $95.07 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $79.17 | 2022-2023 | Dupixent |
| Intercept Pharmaceuticals, INC. | $74.87 | 2022 | |
| Gilead Sciences, INC. | $67.71 | 2022-2023 | |
| Redhill Biopharma INC. | $48.74 | 2021-2023 | Movantik, Talicia, Aemcolo |
| Olympus America INC. | $45.78 | 2021-2022 | |
| Braintree Laboratories, INC. | $41.07 | 2021-2023 | Suflave |
| Nestle Healthcare Nutrition INC. | $21.53 | 2021 | |
| Pfizer INC. | $15.74 | 2024 | |
| Qol Medical, LLC | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.